Another knock for Otezla from the UK

[Fred]

Following on from the bad news for Otezla (apremilast) Germany says Otezla gives no benefit to psoriasis patients today Celgene looks like taking another knock in the UK.

NICE (National Institute for Heath and Care Excellence) look set to say no to Otezla for England and Wales, (Scotland will be getting it however) it looks set to get rejected for use in England and Wales after not meeting cost effectiveness.

Don't ask me why Scotland gets preferential treatment, as far as I know it's a political thing.

*This report is made up from various pieces of information that have been passed on to me, I've not been able to find any official announcement as yet but it looks very likely this is going to happen.

[jiml]

Perhaps in the long term this may be a good strategy . If the companies can't sell their products where they want mainly because of price, perhaps they will have to rethink their pricing policies
England and Wales are not saying it doesn't work, it seems just that it is not cost effective. Perhaps if the cost were the same as methotrexate it may become cost effective

[Fred]

Perhaps in the long term this may be a good strategy . If the companies can't sell their products where they want mainly because of price, perhaps they will have to rethink their pricing policies
England and Wales are not saying it doesn't work, it seems just that it is not cost effective. Perhaps if the cost were the same as methotrexate it may become cost effective

It'll never be the same as methotrexate Jim.

But they did get Stelara cheaper by holding off for psoriatic arthritis use.